Moberg Pharma

19,12SEK -2,35 %
Vær den første som følger denne virksomhed

Moberg Pharma is a Swedish specialist pharmaceutical company focusing on the commercialization of proprietary drugs based on proven substances. The company works primarily in nail fungus, where Moberg Pharma is developing a new topical treatment. The company is in the registration phase in Europe and has agreements with commercial partners in place in Europe and Asia, among other places.

Omsætning
207 t
EBIT %
-9.772,95 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
MOB
Daglig lav / høj pris
19,02 / 19,5 SEK
Markedsværdi
192,84 mio. SEK
Aktieomsætning
46,95 t SEK
Volumen
2,4 t

Finanskalender